Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2002-07-29

Original market date: See footnote 1

1988-12-31

Product name:

M.V.I. PAEDIATRIC

DIN:

01927833 Electronic product monograph is not available

Company:

AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada H7V 0A3

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

13

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

88:28.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05XC VITAMINS

Active ingredient group (AIG) number:See footnote5

1318944001

List of active ingredient(s)
Active ingredient(s) Strength
ASCORBIC ACID 80 MG / VIAL
BIOTIN 20 MCG / VIAL
D-PANTOTHENIC ACID 5 MG / VIAL
FOLIC ACID .14 MG / VIAL
NICOTINAMIDE 17 MG / VIAL
PYRIDOXINE HYDROCHLORIDE 1 MG / VIAL
VITAMIN A 2300 UNIT / VIAL
VITAMIN B1 (THIAMINE HYDROCHLORIDE) 1.2 MG / VIAL
VITAMIN B12 1 MCG / VIAL
VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) 1.4 MG / VIAL
VITAMIN D 400 UNIT / VIAL
VITAMIN E 7 UNIT / VIAL
VITAMIN K1 .2 MG / VIAL
Version 4.0.2
Date modified: